未登录Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study真实世界生存结局、治疗模式及PD-L1表达对加拿大接受CRT→度伐利尤单抗治疗的不可切除、Ⅲ期NSCLC患者的影响：RELEVANCE研究
Wheatley-Price, Paul; Navani, Vishal; Pabani, Aliyah; Routy, Bertrand; Snow, Stephanie; Denault, Marie-Helene; Kim, YongJin; Syed, Iqra; Devost, Natalie; Hui, Daphne; Qadeer, Rana A.; Arora, Paul; Velummailum, Russanthy; Springford, Aaron; McKibbon, Chelsea; Ho, Cheryl .png)
分享.png)
收藏分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
